Journal article
Discovery of pyrido[3,4-g]quinazoline derivatives as CMGC family protein kinase inhibitors: Design, synthesis, inhibitory potency and X-ray co–crystal structure
- Abstract:
- The design and synthesis of new pyrido[3,4-g]quinazoline derivatives is described as well as their protein kinase inhibitory potencies towardfive CMGC family members (CDK5, CK1, GSK3, CLK1 and DYRK1A). The interest for this original tricyclic heteroaromatic scaffold as modulators of CLK1/ DYRK1A activity was validated by nanomolar potencies (compounds 12 and 13).CLK1 co-crystal structures with two inhibitors revealed the binding mode of these compounds within the ATPbinding pocket.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 684.2KB, Terms of use)
-
- Publisher copy:
- 10.1016/j.ejmech.2016.04.004
Authors
- Publisher:
- Elsevier
- Journal:
- European Journal of Medicinal Chemistry More from this journal
- Volume:
- 118
- Pages:
- 170-177
- Publication date:
- 2016-04-01
- Acceptance date:
- 2016-04-02
- DOI:
- Keywords:
- Pubs id:
-
pubs:624365
- UUID:
-
uuid:39494b46-5603-44db-95ff-51679ee07206
- Local pid:
-
pubs:624365
- Source identifiers:
-
624365
- Deposit date:
-
2016-05-27
Terms of use
- Copyright holder:
- Elsevier Masson SAS
- Copyright date:
- 2016
- Notes:
- © 2016 Elsevier Masson SAS. All rights reserved.
If you are the owner of this record, you can report an update to it here: Report update to this record